BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 17163813)

  • 1. Blood transfusions in athletes. Old dogmas, new tricks.
    Lippi G; Banfi G
    Clin Chem Lab Med; 2006; 44(12):1395-402. PubMed ID: 17163813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood transfusion in sports.
    Giraud S; Sottas PE; Robinson N; Saugy M
    Handb Exp Pharmacol; 2010; (195):295-304. PubMed ID: 20020370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood doping: risks to athletes' health and strategies for detection.
    Oliveira CD; Bairros AV; Yonamine M
    Subst Use Misuse; 2014 Jul; 49(9):1168-81. PubMed ID: 24766400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood doping: the flip side of transfusion and transfusion alternatives.
    Cacic DL; Hervig T; Seghatchian J
    Transfus Apher Sci; 2013 Aug; 49(1):90-4. PubMed ID: 23791798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of autologous blood transfusions in athletes: a historical perspective.
    Mørkeberg J
    Transfus Med Rev; 2012 Jul; 26(3):199-208. PubMed ID: 22119492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current strategic approaches for the detection of blood doping practices.
    Segura J; Ventura R; Pascual JA
    Forensic Sci Int; 2011 Dec; 213(1-3):42-8. PubMed ID: 21889274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection methods for autologous blood doping.
    Segura J; Monfort N; Ventura R
    Drug Test Anal; 2012 Nov; 4(11):876-81. PubMed ID: 22407819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical experience with the implementation of an athlete's biological profile in athletics, cycling, football and swimming.
    Zorzoli M; Pipe A; Garnier PY; Vouillamoz M; Dvorak J
    Br J Sports Med; 2014 May; 48(10):862-6. PubMed ID: 24648438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting doping use: more than an analytical problem.
    Delanghe JR; Maenhout TM; Speeckaert MM; De Buyzere ML
    Acta Clin Belg; 2014; 69(1):25-9. PubMed ID: 24635395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A DNA-based method for detecting homologous blood doping.
    Manokhina I; Rupert JL
    Anal Bioanal Chem; 2013 Dec; 405(30):9693-701. PubMed ID: 23842898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible cause of lack of positive samples on homologous blood transfusion.
    Krotov G; Nikitina M; Rodchenkov G
    Drug Test Anal; 2014; 6(11-12):1160-2. PubMed ID: 25331764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of common hematologic abnormalities on the ability of blood models to detect erythropoietin abuse by athletes.
    Parisotto R; Ashenden MJ; Gore CJ; Sharpe K; Hopkins W; Hahn AG
    Haematologica; 2003 Aug; 88(8):931-40. PubMed ID: 12935982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards the identification of autologous blood transfusions through capillary electrophoresis.
    Harrison CR; Fang JC; Walthall KJ; Green CC; Porobic V
    Anal Bioanal Chem; 2014 Jan; 406(3):679-86. PubMed ID: 24281324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous Blood Transfusion in Sports: Emerging Biomarkers.
    Salamin O; De Angelis S; Tissot JD; Saugy M; Leuenberger N
    Transfus Med Rev; 2016 Jul; 30(3):109-15. PubMed ID: 27260108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood doping : infusions, erythropoietin and artificial blood.
    Eichner ER
    Sports Med; 2007; 37(4-5):389-91. PubMed ID: 17465616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sports drug testing for erythropoiesis-stimulating agents and autologous blood transfusion.
    Reichel C
    Drug Test Anal; 2012 Nov; 4(11):803-4. PubMed ID: 22927317
    [No Abstract]   [Full Text] [Related]  

  • 17. [Doping in endurance sports. Survey of individual [Hb] levels can expose doping].
    Ekblom B; Holmberg HC; Eriksson K
    Lakartidningen; 2001 Nov; 98(48):5490-2, 5495-6. PubMed ID: 11769364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood doping in athletes--detection of allogeneic blood transfusions by flow cytofluorometry.
    Arndt PA; Kumpel BM
    Am J Hematol; 2008 Aug; 83(8):657-67. PubMed ID: 18508326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red blood cell populations and membrane levels of peroxiredoxin 2 as candidate biomarkers to reveal blood doping.
    Marrocco C; Pallotta V; D'alessandro A; Alves G; Zolla L
    Blood Transfus; 2012 May; 10 Suppl 2(Suppl 2):s71-7. PubMed ID: 22890272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for autologous blood transfusions.
    Mørkeberg J; Belhage B; Ashenden M; Bornø A; Sharpe K; Dziegiel MH; Damsgaard R
    Int J Sports Med; 2009 Apr; 30(4):285-92. PubMed ID: 19199200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.